Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Transfusion. 2010 Dec;50(12):2738–2744. doi: 10.1111/j.1537-2995.2010.02748.x

Table 4. Combined TRALI and TACO incidence by blood component pre- and post-implementation of universal leukoreduction.

Pre–universal
leukoreduction
TRALI/TACO
(n; incidence)
1993-1999		 Post–universal
leukoreduction
TRALI/TACO
(n; incidence)
2001-2007		 Odds Ratio
Post-/Pre-ULR
(95% confidence
interval)		 Net Change
In
Incidence
Cryoprecipitate
(Cryo)		 1 of 19,152 (5.2) 0 of 18,870 (0) 0.33 (0.01 – 8.1) −100%
Fresh Frozen
Plasma (FFP)		 6 of 56,201 (11)* 7 of 87,744
(8.0)* 		0.75 (0.25 – 2.2) −27%
Red Cells (RBC) 22 of 147,789 (15)* 10 of 173,244
(5.8*)		 0.39 (0.18 – 0.82) −61%
Platelets 8 of 139,642 (5.7*) 1 of 135,917
(0.7*)		 0.13 (0.02 –1.03) −88%
Total FFP/Cryo 7 of 75,353 (9.3)* 7 of 106,614
(6.6)* 		0.71 (0.25 –2.0) −29%
Total
RBC/Platelets		 30 of 287,431 (10)* 11 of 309,161
(3.6)* 		0.34 (0.17 – 0.68) −64%
*

Rate per 100,000 components transfused